Literature DB >> 15729071

Ischemic preconditioning impairs liver regeneration in extended reduced-size livers.

Christian Eipel1, Matthias Glanemann, Andreas K Nuessler, Michael D Menger, Peter Neuhaus, Brigitte Vollmar.   

Abstract

OBJECTIVE: To evaluate the effect of ischemic preconditioning (IPC) in an experimental setting of extended liver resection with 30 minutes of inflow occlusion in rats. SUMMARY BACKGROUND DATA: IPC has been proven an effective strategy against hepatic ischemia-reperfusion injury in both animal and human studies. However, decreased protective effects in terms of transaminase levels were found in patients with larger resection volume, questioning the benefit of IPC in case of small liver remnants.
METHODS: Rats undergoing 90% hepatectomy under strict inflow occlusion for 30 minutes were subjected to either receive or not receive an IPC period (5 minutes of ischemia followed by 30 minutes of reperfusion). In addition to 10-day survival rate, laser Doppler flowmetry of hepatic blood flow and fluorescence microscopic analysis of the hepatic microcirculation were performed to assess the effect of IPC on initial microvascular reperfusion of liver remnants after 90% resection. Moreover, regeneration capacity of livers undergoing IPC and 70% resection was studied over 7 days by means of histology and immunohistochemistry.
RESULTS: Ten-day survival of rats which underwent IPC and 90% hepatectomy was 0 out of 10 animals versus 1 out of 10 animals without IPC. Hemodynamic and microcirculatory analysis revealed signs of hyperperfusion during initial reperfusion of preconditioned liver remnants in 90% hepatectomized animals. In addition to increased transaminase levels, IPC impaired hepatic proliferative response after 70% organ resection, as indicated by both a significant reduction in mitotic figures and Ki-67 nuclear staining of hepatocytes, as well as a decrease in restitution of liver mass.
CONCLUSIONS: Though portal hypertension reflecting shear stress has been reported to trigger liver regeneration, remnant liver tissue after major hepatectomy may not benefit from hyperperfusion-induced trigger for cell cycle entry but is rather dominated from hyperperfusion-induced local organ injury. Further studies are required to finally judge on the harmfulness of IPC in extended liver resection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15729071      PMCID: PMC1356987          DOI: 10.1097/01.sla.0000154264.41201.51

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  50 in total

Review 1.  Preservation injury of the liver: mechanisms and novel therapeutic strategies.

Authors:  M Bilzer; A L Gerbes
Journal:  J Hepatol       Date:  2000-03       Impact factor: 25.083

2.  Preconditioning protects against ischemia/reperfusion injury of the liver.

Authors:  B Nilsson; S Friman; B I Gustafsson; D S Delbro
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

3.  Vagus nerve is involved in lack of blood reflow into sinusoids after rat hepatic ischemia.

Authors:  T Nishida; S Ueshima; H Kazuo; T Ito; A Seiyama; H Matsuda
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

Review 4.  Pathophysiology of ischaemia-reperfusion injury.

Authors:  D L Carden; D N Granger
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

5.  Minimum graft size for successful living donor liver transplantation.

Authors:  C M Lo; S T Fan; C L Liu; J K Chan; B K Lam; G K Lau; W I Wei; J Wong
Journal:  Transplantation       Date:  1999-10-27       Impact factor: 4.939

6.  Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death.

Authors:  T Schäfer; C Scheuer; K Roemer; M D Menger; B Vollmar
Journal:  FASEB J       Date:  2003-04       Impact factor: 5.191

7.  Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation?

Authors:  Roberto Troisi; Guy Cammu; Giuseppe Militerno; Luc De Baerdemaeker; Johan Decruyenaere; Eric Hoste; Peter Smeets; Isabelle Colle; Hans Van Vlierberghe; Mirko Petrovic; Dirk Voet; Eric Mortier; Uwe J Hesse; Bernard de Hemptinne
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

8.  Analysis of failure in living donor liver transplantation: differential outcomes in children and adults.

Authors:  Michael J Goldstein; Ephrem Salame; Sandip Kapur; Milan Kinkhabwala; Diane LaPointe-Rudow; Patricia Harren N P; Steven J Lobritto; Mark Russo; Robert S Brown; Guellue Cataldegirmen; Alan Weinberg; John F Renz; Jean C Emond
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

9.  Relationship between portal venous flow and liver regeneration in patients after living donor right-lobe liver transplantation.

Authors:  Susumu Eguchi; Katsuhiko Yanaga; Nozomu Sugiyama; Sadayuki Okudaira; Junichiro Furui; Takashi Kanematsu
Journal:  Liver Transpl       Date:  2003-06       Impact factor: 5.799

10.  Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression.

Authors:  Kwan Man; Sheung-Tat Fan; Chung-Mau Lo; Chi-Leung Liu; Peter Chin-Wan Fung; Ting-Bo Liang; Terence Kin-Wah Lee; Steven Hung-Teng Tsui; Irene Oi-Lin Ng; Zhi-Wei Zhang; John Wong
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more
  19 in total

Review 1.  Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.

Authors:  Christian Eipel; Kerstin Abshagen; Brigitte Vollmar
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Ischemic preconditioning impairs liver regeneration in extended reduced-size livers.

Authors:  Mohammed M Habib; Clare Selden; Humphrey Hodgson; Brian R Davidson
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection.

Authors:  Astrit R Hamza; Avdyl S Krasniqi; Pramod Kadaba Srinivasan; Mamdouh Afify; Christian Bleilevens; Uwe Klinge; René H Tolba
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  Platelet transfusion can be related to liver regeneration after living donor liver transplantation.

Authors:  Joohyun Kim; Nam-Joon Yi; Woo Young Shin; Taehoon Kim; Kuhn Uk Lee; Kyung-Suk Suh
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

5.  [Standard surgical resection of colorectal liver metastases].

Authors:  W O Bechstein; M Golling
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

6.  Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice.

Authors:  Khoi Le Minh; Katja Klemm; Kerstin Abshagen; Christian Eipel; Michael D Menger; Brigitte Vollmar
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

7.  Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of D-galactosamine-sensitized mice to lipopolysaccharide.

Authors:  C Eipel; E Kidess; K Abshagen; K Leminh; M D Menger; H Burkhardt; B Vollmar
Journal:  Br J Pharmacol       Date:  2007-04-10       Impact factor: 8.739

8.  Anesthetic Considerations in Hepatectomies under Hepatic Vascular Control.

Authors:  Aliki Tympa; Kassiani Theodoraki; Athanassia Tsaroucha; Nikolaos Arkadopoulos; Ioannis Vassiliou; Vassilios Smyrniotis
Journal:  HPB Surg       Date:  2012-05-28

9.  Influence of portosystemic shunt on liver regeneration after hepatic resection in pigs.

Authors:  R Ladurner; M Schenk; R Margreiter; F Offner; A Königsrainer
Journal:  HPB Surg       Date:  2009-09-24

10.  The effect of warm liver ischaemia & reperfusion injury on circulating plasma lipid levels & lipolytic enzyme activity in rat & the impact of ischaemic preconditioning.

Authors:  Sophocles Lanitis; Evangelos Lolis; Nikolaos Dafnios; George Sgourakis; Dionysios C Voros; Ioannis Vassiliou
Journal:  Indian J Med Res       Date:  2012-08       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.